Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)

M. K. Kwok; G. M. Leung; L. Xu; H. F. Tse; T. H. Lam; T. H. So; C. M. Schooling

Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)

M. K. Kwok
, G. M. Leung
, L. Xu
, H. F. Tse
, T. H. Lam
, T. H. So
, C. M. Schooling

Population Health

Research output: Contribution to journal › Comment/debate

2 Citations (Scopus)

Original language	English
Pages (from-to)	18-21
Number of pages	4
Journal	Hong Kong Medical Journal
Volume	29
Issue number	4
Publication status	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{afb2f96fd5bb497d870cb6c7efe7d272,

title = "Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)",

author = "Kwok, \{M. K.\} and Leung, \{G. M.\} and L. Xu and Tse, \{H. F.\} and Lam, \{T. H.\} and So, \{T. H.\} and Schooling, \{C. M.\}",

year = "2023",

language = "English",

volume = "29",

pages = "18--21",

number = "4",

}

TY - JOUR

T1 - Effects of puerarin supplementation on cardiovascular disease risk factors

T2 - a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)

AU - Kwok, M. K.

AU - Leung, G. M.

AU - Xu, L.

AU - Tse, H. F.

AU - Lam, T. H.

AU - So, T. H.

AU - Schooling, C. M.

PY - 2023

Y1 - 2023

UR - https://www.scopus.com/pages/publications/85170486220

M3 - Comment/debate

C2 - 37690802

AN - SCOPUS:85170486220

SN - 1024-2708

VL - 29

SP - 18

EP - 21

JO - Hong Kong Medical Journal

JF - Hong Kong Medical Journal

IS - 4

ER -

Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication)

UN SDGs

Other files and links

Cite this